Using AI to create easy-to-understand summaries of eye care notes
Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
NA · University of California, Los Angeles · NCT06859216
This study is testing if using AI to create simpler summaries of eye care notes can help patients understand their diagnosis and treatment better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 460 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, Los Angeles (other) |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT06859216 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates whether plain language summaries generated by artificial intelligence can enhance patient understanding of ophthalmology notes. Adults receiving eye care at the Jules Stein Eye Institute will be randomly assigned to receive either standard medical notes or notes supplemented with AI-generated summaries that simplify complex information. Participants will complete a survey to assess their comprehension of their diagnosis and treatment, as well as their confidence in their care. The study aims to improve communication between patients and healthcare providers through clearer information.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults aged 18 and older who are receiving ophthalmology care at the Jules Stein Eye Institute.
Not a fit: Patients with known cognitive impairments or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance patient comprehension and confidence in their eye care.
How similar studies have performed: Other studies have shown promise in using AI for patient education, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years English-speaking Receiving ophthalmology care at the Jules Stein Eye Institute Able to provide informed consent Exclusion Criteria: * Known cognitive impairments (e.g., dementia, intellectual disability) that would affect comprehension Prisoners or wards of the state Unable to provide informed consent
Where this trial is running
Los Angeles, California
- UCLA — Los Angeles, California, United States (RECRUITING)
Study contacts
- Principal investigator: Prashant Tailor, MD — University of California, Los Angeles
- Study coordinator: Prashant Tailor, MD
- Email: ptailor@mednet.ucla.edu
- Phone: 4043166920
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ophthalmic Disease, Artifical Intelligence, Large Language Model, Plain Language Summary, LLM, Patient education